A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

NCT01181024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic, Healthy Volunteer

Interventions

DRUG: Placebo
DRUG: RO5303253
DRUG: RO5303253
DRUG: RO5303253

Sponsor

Hoffmann-La Roche